Though muscular dystrophies due to LAMA2-related muscular dystrophy is relatively rare, they cover a distinct clinical presentations and severity with high disability and disease burden, and the further mechanism how the pathogenic variants affect the function of laminin-α2 leading to clinical heterogeneity is still unclear. The gene discussed is LAMA2; the disease is muscular dystrophy.